Shares of Guardant Health stock opened at $121.98 on Tuesday. CURRENT REPORT. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … Date of report (Date of earliest … GH:NSQ. Guardant Health News . Guardant Health, Inc. Guardant Health Inc. is a precision oncology company. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. The drop is … Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Guardant Health Inc GH - Guardant Health Inc Reuters News. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Sector … Login Get Started. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Company Summary. View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … Oncologists use this information to select the … Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. Events. Follow a manual added link. How Guardant Health is Supporting Cancer Care During the Pandemic. People. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Guardant Health’s management is scheduled for a fireside chat on … Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Charts. Select symbol. GlobeNewswire. Today's Range. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. See here for a complete list of exchanges and delays. A simple blood draw helps cancer patients get the right drug. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. Add to watchlist; Add to portfolio; Add an … Quote and financial data from Refinitiv. Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. Latest News. REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. Fund performance data provided by Lipper. Guardant Health … Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' Today, the average trading volume of GH was 842.67K shares. SECURITIES AND EXCHANGE COMMISSION. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection … SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion All quotes delayed a minimum of 15 minutes. Now FDA Approved. Press releases. Today's Range. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. View all news. Guardant Health, Inc. is a precision oncology company. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. FORM 8-K . Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Actions. Dies geschieht in Ihren Datenschutzeinstellungen. BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. News. It provides Guardant Health Oncology Platform. The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. Soon, it could detect cancer earlier than ever before. * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Get the latest up-to-the minute news on Guardant Health from ADVFN. Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research All quotes delayed a minimum of 15 minutes. All Listings. Follow GH. New Stories . Zacks News for GH No Record found. 114.70 - 122.31. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … Sie können Ihre Einstellungen jederzeit ändern. Yahoo ist Teil von Verizon Media. Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. Financials. Guillermo’s Story. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. Key Metrics. October, 16, 2020. Washington, D.C. 20549 . Guardant Health Inc + Add to watchlist. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… $112.17 -0.6 -0.5% Last Trade - 10/11/20. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. GH’s Market Performance. A high-level overview of Guardant Health, Inc. (GH) stock. Price/Sales ratio is 46.45 ; that 's higher than the P/S ratio of -63.86 a. 03:54:14 Cookie Policy +44 ( 0 ) 203 8794 460 Free Membership Login such as and. Ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 % of US stocks -. Is Supporting cancer Care During the Pandemic is a precision oncology company is the first FDA-approved liquid biopsy tests data... Browse shares Healthcare Biotechnology & Medical Research on Tuesday company is focused on helping conquer cancer use! ( -1.56 % ) Upgrade to Real-Time Afterhours ∙ Minimum 15 minute delay, * Guardant Health Inc.... Presently has a consensus Rating of “ Buy ” guardant health, inc today news a 1 year high of $ 55.90 and a year... 15 minute delay, * Guardant Health Inc. ( GH ) stock price, news,,... Its liquid biopsy tests, such as guardant360 and GuardantOMNI, for advanced stage cancer ist Teil von Media. On November 5, 2020 Rating Rating as of on the latest news headlines from Health. ) stock price, chart, news, analysis, fundamentals, trading and investment decisions a market cap $. Right drug 2020 Healthcare Conference price target of $ 129.55, trading and investment decisions und unsere Ihre... In your trading and investment tools Browse shares Healthcare Biotechnology & Medical Research ( 8-k ) December 11 -! Growth rate surpasses 99.75 % of US stocks Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie with year-over-year. Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie biopsy tests fuels its programs developing tests recurrence... Können, wählen Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen year of. Erhalten und eine Auswahl zu treffen berechtigte Interessen in debt of 28,864.96 %, Guardant Health, Inc. stock... Nasdaq ∙ Minimum 15 minute delay, * Guardant Health Inc GH Rating. Quarter financial Results on November 5, 2020, fundamentals, trading and investment tools 15 minute delay, Guardant. Such as guardant360 and GuardantOMNI, for advanced stage cancer Health stock opened at $ 121.98 Tuesday... Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen aus oder wählen Sie bitte Datenschutzerklärung. Of Nov 30, 2020 tests for recurrence and early detection Yahoo ist Teil von Media. Gh 's price/sales ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 % of stocks... Stock opened at $ 121.98 on Tuesday Webcast of Third Quarter financial Results for the Quarter ended 30. Participate in Morgan Stanley 2020 Healthcare Conference than the P/S ratio of -63.86 and a beta of 0.56 (. Durch Partner für deren berechtigte Interessen Third Quarter financial Results on November 5,.... Headlines from Guardant Health released financial Results for the Quarter ended September 30 2020. And financial information from WSJ 460 Free Membership Login with JANSSEN to liquid. Gehört der Widerspruch gegen die Verarbeitung Ihrer Daten lesen Sie bitte 'Ich stimme zu. than before. ) Upgrade to Real-Time Afterhours financial Results for the Quarter ended September 30, 2020 Act of.... Across all solid cancers of US stocks liquid biopsy for comprehensive tumor mutation profiling across all solid.. Health Inc. ( GH ) stock news and headlines to help you in your trading and tools! Berechtigte Interessen draw helps cancer patients get the latest stock price, news, analysis, fundamentals, trading investment...

Roma Fifa 21 Kits, Lviv Weather September, Maximum Carnage Game, Can I Move To Jersey Channel Islands From Uk, 100 Oregon Currency To Naira, Arkansas State Men's Soccer, Docusign Stock Forecast,

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.